EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 62 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,895 | -4.5% | 21,764 | +4.0% | 0.00% | – |
| Q2 2023 | $182,125 | +148.8% | 20,934 | -15.9% | 0.00% | – |
| Q1 2023 | $73,206 | +101.0% | 24,900 | +139.3% | 0.00% | – |
| Q4 2022 | $36,425 | -55.0% | 10,407 | +1.7% | 0.00% | – |
| Q3 2022 | $81,000 | -13.8% | 10,232 | -14.6% | 0.00% | – |
| Q2 2022 | $94,000 | -32.4% | 11,975 | +4.6% | 0.00% | – |
| Q1 2022 | $139,000 | -11.5% | 11,453 | -10.8% | 0.00% | – |
| Q4 2021 | $157,000 | -93.0% | 12,835 | -94.0% | 0.00% | -100.0% |
| Q3 2021 | $2,242,000 | +15.7% | 215,199 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,938,000 | – | 215,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |